NMPA Approval

Omalizumab alfa for Injection

Approval Number

国药准字S20230031

Company泰州迈博太科药业有限公司

Registration Date

May 19, 2023

Drug Information

Generic Name

注射用奥马珠单抗α

Dosage Form

注射剂

Strength

150mg/瓶

Drug Type

生物制品

Registration Date

May 19, 2023

Company Information

Applicant Company

Company Name泰州迈博太科药业有限公司

Company Address

泰州市中国医药城口泰路西侧、陆家路东侧G79幢

Manufacturing Company

Company Name泰州迈博太科药业有限公司

Company Address

泰州市中国医药城口泰路西侧、陆家路东侧G79幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用奥马珠单抗α - NMPA 批准文号 | MedPath